ANN ARBOUR, Mich.–(BUSINESS WIRE)–ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer in enhanced ultrasound technologies, today announced that management will participate in the JMP Securities Life Sciences Conference to be held June 15-16, 2022 in New York City. Management to present company overview on Wednesday, June 15e at 2:30 p.m. Eastern Time and will host one-on-one meetings with investors. To request a meeting, please contact JMP Securities or Yvonne Briggs of LHA at [email protected]
About ENDRA Life Sciences Inc.
ENDRA Life Sciences is the pioneer of enhanced thermo-acoustic ultrasound (TAEUS®), a revolutionary technology being developed to visualize tissue like MRI, but at 1/50e cost and at the point of patient care. TAEU® is designed to work in concert with more than 500,000 ultrasound systems currently in use around the world. TAEU® initially focused on measuring fat in the liver as a way to assess and monitor non-alcoholic fatty liver disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect more than one billion people worldwide. the world and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy surgeries. For more information, please visit www.endrainc.com.